TARO - Taro Pharmaceutical EPS misses by $0.26 misses on revenue November, 04 2019 05:06 PM Taro Pharmaceutical Industries Ltd. Taro Pharmaceutical (NYSE:TARO): Q3 GAAP EPS of $1.46 misses by $0.26.More news on: Taro Pharmaceutical Industries Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...